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Abstract: Introduction The purpose of this study was to compare diagnostic accuracy of a prostate
multiparametric magnetic resonance imaging (mpMRI) protocol for detection of prostate cancer between
images acquired with and without en-dorectal coil (ERC). Materials This study was approved by the
regional ethics committee. Between 2014 and 2015, 33 patients (median age 51.3 years; range 42.1-77.3
years) who underwent prostate-MRI at 3T scanners at 2 different institutions, acquired with (mpMRI)
and without (mpMRI) ERC and who received radical prostatectomy, were included in this retrospective
study. Two expert readers (R1, R2) attributed a PI-RADS version 2 score for the most suspect (i. e.
index) lesion for mpMRI and mpMRI. Sensitivity and positive predictive value for detection of index
lesions were assessed using 2 × 2 contingency tables. Differences between groups were tested using
the McNemar test. Whole-mount histopathology served as reference standard. Results On a quadrant-
basis cumulative sensitivity ranged between 0.61-0.67 and 0.76-0.88 for mpMRI and mpMRI protocols,
respectively (p > 0.05). Cumulative positive predictive value ranged between 0.80-0.81 and 0.89-0.91 for
mpMRI and mpMRI protocols, respectively. The differences were not statistically significant for R1 (p
= 0.267) or R2 (p = 0.508). Conclusion Our results suggest that there may be no significant differences
for detection of prostate cancer between images acquired with and without an ERC.
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Introduction: The purpose of this study was to compare di-
agnostic accuracy of a prostate multiparametric magnetic 
resonance imaging (mpMRI) protocol for detection of pros-
tate cancer between images acquired with and without en-
dorectal coil (ERC). Materials: This study was approved by 
the regional ethics committee. Between 2014 and 2015, 33 
patients (median age 51.3 years; range 42.1–77.3 years) who 
underwent prostate-MRI at 3T scanners at 2 different insti-
tutions, acquired with (mpMRIERC) and without (mpMRIPPA) 
ERC and who received radical prostatectomy, were included 
in this retrospective study. Two expert readers (R1, R2) at-
tributed a PI-RADS version 2 score for the most suspect (i. 
e. index) lesion for mpMRI
PPA
 and mpMRIERC. Sensitivity and 
positive predictive value for detection of index lesions were 
assessed using 2 × 2 contingency tables. Differences be-
tween groups were tested using the McNemar test. Whole-
mount histopathology served as reference standard. Results: 
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Introduction
While biopsy is still the gold standard for establish-
ing the diagnosis of prostate cancer, multiparametric 
magnetic resonance imaging (mpMRI) has become an 
indispensable test in the diagnostic pathway of patients 
with suspected prostate cancer. It plays an important role 
within the setting of cancer detection [1], tumor local-
ization [2, 3] and assessment of cancer aggressiveness 
On a quadrant-basis cumulative sensitivity ranged between 
0.61–0.67 and 0.76–0.88 for mpMRI
PPA
 and mpMRIERC proto-
cols, respectively (p > 0.05). Cumulative positive predictive 
value ranged between 0.80–0.81 and 0.89–0.91 for mpMRI
PPA
 
and mpMRIERC protocols, respectively. The differences were 
not statistically significant for R1 (p = 0.267) or R2 (p = 0.508). 
Conclusion: Our results suggest that there may be no sig-
nificant differences for detection of prostate cancer between 
images acquired with and without an ERC.
*These authors contributed equally, and hence share the first authorship.
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[4, 5]. In order to contribute valuable information for pa-
tient management, however, mpMRI must be performed 
and interpreted following high quality standards [6, 7]. 
Appropriate image quality is indispensable when inter-
preting mpMRI in order to establish a correct diagnosis 
of prostate cancer. Recommendations on minimal re-
quirements on MRI soft- and hardware have been pub-
lished [8], however no explicit recommendation is given 
regarding receiver coil setup. While an endorectal coil 
(ERC) may be particularly valuable for sequences with 
inherently lower signal-to-noise ratio (SNR), increased 
costs, artifacts and patient acceptance remain limiting 
factors. The ERC was shown to be useful with 1.5T 
scanners, where the increase in SNR directly translated 
into an improvement in diagnostic performance [9]. For 
3T scanners and pelvic phased array (PPA) receiver coil 
equipment, the situation is not as clear. While it has been 
shown that using comparable sequence parameters, simi-
lar image quality for ERC and surface receiver coil (SRC) 
may be achieved [10], other studies [11–13] have demon-
strated similar diagnostic accuracy with both coil settings 
despite lower image quality achieved with the SRC con-
figuration. These studies however, did not investigate the 
diagnostic performance of a complete mpMRI protocol 
consisting of T2-weighted (T2w), diffusion-weighted 
imaging (DWI) and dynamic contrast enhanced (DCE) 
images and did not use whole-mount histopathology as 
the standard of reference. Another study has shown supe-
rior diagnostic accuracy in the detection of prostate can-
cer using an ERC configuration as compared to a SRC 
configuration [14], however the sequence parameters 
for the two coil configurations were not normalized in 
this setting. Given the equivocal results of single center 
studies on this topic, further investigations on receiver 
coil configuration are needed using comparable and op-
timized imaging protocols for both configurations with 
whole-mount histopathology as the standard of reference. 
Therefore, the purpose of this multicenter study was 
to assess the diagnostic accuracy for prostate cancer de-
tection between MRI protocols acquired with and with-
out an ERC using similar sequence parameters.
Materials and Methods
The regional ethics committees approved this multicenter 
study, which was designed as a part of a wider cancer research 
project at our institution and written informed consent was ob-
tained from all patients prior to the examination. The study was 
compliant with the Health Insurance Portability and Accountabil-
ity Act.
Study Population
Consecutive patients undergoing mpMRI of the prostate at 3T 
(Tesla) acquired with two receiver coil setups, i. e. a combina-
tion of an endorectal and a PPA receiver coil (mpMRI
ERC
), and a 
PPA receiver coil only (mpMRI
PPA
), followed by a radical pros-
tatectomy were retrospectively included into the study (n = 38; 
median age 67.8 years; range 51.3–77.3 years). The exams were 
performed within a clinical setting for either detection and/or lo-
cal staging of prostate cancer between December 2014 and Au-
gust 2015 at two radiology departments. Clinical indications were 
elevated prostate specific antigen (PSA) (median PSA 5.8 μg/l, 
range 0.3–46.0 μg/l) or suspicion of prostate cancer on digital rec-
tal examination. We excluded patients with an incomplete histopa-
thology report (n = 5). The final study population comprised of 33 
patients (median age 51.3 years, range 42.1–77.3 years). Three of 
these patients previously had been included in a study comparing 
diagnostic accuracy of a standard versus shortened multiparamet-
ric MRI protocol [29], and 13 patients were previously included in 
a study comparing image quality of images with and without ERC 
[10]. Patient demographics and a summary of histopathology data 
is shown in table 1.
MRI Equipment 
Images were acquired on a 3T whole body MRI system 
(MAGNETOM Skyra, Siemens Healthcare®, Erlangen, Germany) 
in both radiologic departments. First, the mpMRI
ERC
 image set 
Table 1. Patient demographics and histopathology data
Demographic parameter
Age, year*
PSA at time of MRI imaging (μg/l)*
Time interval between mpMRI and histopathology, 
day*
Prostatectomy specimen with extracapsular extension**
Prostatectomy specimen with seminal vesicle infiltra-
tion**
Prostatectomy specimen surgical margins**
      R0
R1
Pathological stage**
      2a
      2b
      2c
      3a
      3b
Prevalence of index Gleason scores on histopathol-
ogy**
      3 + 3
      3 + 4
      4 + 3
      4 + 4
      4 + 5




















      Thirty-three patients are in the dataset. *Data are means; data in squared 
parentheses are ranges. **Data are absolute counts; data in parentheses are 
percentages.
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was acquired using an 18-channel PPA receiver coil (Body 18, 
Siemens Healthcare®, Erlangen, Germany) in conjunction with 
a balloon-covered, expandable ERC (Medrad, Warrendale, Pa) 
filled with barium suspension. Secondly, the ERC was removed 
and images for the mpMRI
PPA
 image set were acquired using the 
PPA receiver coil only. 
Scan Parameters
T2w turbo-spin echo images were acquired in three orthogonal 
planes (axial, sagittal and coronal), covering the prostate gland 
and the seminal vesicles. DWI and echo-planar images were ac-
quired with identical orientation as the axial T2w, and utilizing 
selective-excitation technology (ZOOMIt, Siemens Healthcare, 
Erlangen, Germany). Apparent diffusion coefficient (ADC) maps 
were calculated using a mono-exponential fit based on the three 
obtained b-values (either 0, 50, 1,000 s/mm2). A high-b-value 
(1,400 s/mm2) was calculated based upon a standard mono-ex-
ponential fit. T1w turbo-spin echo images were acquired in ax-
ial plane, using a field-of-view encompassing the whole pelvis. 
DCE-MRI were obtained in axial plane with a temporal resolu-
tion of < 8 seconds. Gadoterate meglumine (Dotarem; Guerbet, 
Darmstadt, Germany) was used as contrast agent with a dose of 
0.1 mmol/kg bodyweight. Injection was performed with an auto-
mated MR injection system (Spectris Solaris EP, MEDRAD MR 
Injector, Bayer HealthCare LCC, Whippany NJ) at a flow rate of 
2 ml/s. Sequence parameters were kept within ranges of published 
technical MRI guidelines [8]. Coronal and sagittal T2w images 
and transverse T1w turbo-spin echo images were additionally ob-
tained during the clinical protocol but were not used for study 
purposes. Sequence parameters are shown in table 2.
Image Readout
Study images were de-identified. Blinding of the 2 image sets 
regarding to whether the images were acquired with or without the 
ERC was not possible. Two radiologists (reader 1 and 2) special-
ized in urogenital imaging (O. F. D. with 4 years and A. C. with 10 
years of experience in interpreting prostate MRI) from different 





 image sets randomly in 2 separate reading sessions 
(time interval between the sessions > 4 weeks). DCE-MRI images 
were acquired with ERC only, and were presented in both read-
ing sessions. The readers were aware that patients received radical 
prostatectomy, but were blinded to the remaining clinical informa-
tion. The readers were instructed to assess the visually most sus-
picious lesion (hereafter termed “index lesion”) according to the 
prostate imaging reporting and data system (PI-RADS) version 
Fig. 1. A 67-year-old patient (PSA, 30 ng/ml) undergoing mpMRI of the prostate for cancer detection and local 
staging. T2w (A, C) and ADC maps (B, D) were used side-by-side with histopathology for correlation of every 
mismatched lesion. Reconstructed whole-mount histopathology (E) reveals a 4 + 4 tumor (approximately 160 
mm2) on the left aspect of the peripheral zone, at the level of the midgland (E, green ROI). At one of the two 
institutions the slices were digitalized and the lesions outlined electronically. T2w images with corresponding 
ADC maps from the mpMRI
ERC
 (A, B) and mpMRI
PPA
 (C, D) sets and a whole-mount histopathology (E) from the 
midgland are shown. The corresponding PI-RADS reader score was 4 for both readers and for both image sets.
Gleason 4 + 4
160 mm2
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2 criteria [15] for each patient. Both readers had previously used 
the PI-RADS within their clinical routine and thus were familiar 
with it. The index lesion was attributed to one of the eight equal 
prostate sectors (anterior right, posterior right, anterior left and 
posterior left; four each within the apex and the base of the gland), 
which was a modification of the 36-sector map proposed by PI-
RADS version 2 [15]. Lesions involving more than 1 sector were 
attributed to the predominantly involved sector.
The readout was performed using an electronic reader form 
and patient data was stored on a secured mobile hard drive at our 
institution.
Reference Standard
Histopathology was performed by experienced genitourinary 
pathologists (N.J.R. with 5 and R.G with 20 years of experience in 
interpreting prostatectomies). Each prostate specimen was forma-
lin fixed, processed and embedded in paraffin in axial orientation 
and perpendicularly to the urethra. Five millimeter (mm) thick tis-
sue blocks were made from the apex to the base, labelled sequen-
tially and stained with hematoxylin-eosin for histopathological 
evaluation. Morphological grading was performed according to 
the standards of the ISUP Gleason Grading of Prostatic Carcinoma 
[16]. Gleason score (GS), topographic location and the maximal 
diameter were assigned to the lesion with the highest GS, or if 2 or 
more equally scored lesions were present, the one with the largest 
diameter (i. e. index lesion). Pathological staging was performed 
according to the 8th edition of the Union for International Cancer 
Control TNM classification of malignant tumours [17]. In one of 
the 2 institutions the slices were digitalized, whole slides recon-
structed and all lesions, including the index lesion, were outlined 
electronically including information about exact area and GS (fig. 
1). In the other institution, the lesions were manually mapped on 
a standardized template sheet, which subdivided the prostate into 
16 sectors (i. e. 4 quadrants within the apex, apex-to-midgland, 
midgland-to-base and base, respectively). 
Post-processing of Readout and Histopathology Data 
A third radiologist (B. K. B. 3 years of experience in inter-
preting prostate MRI) not involved in the readout performed the 
post-processing. First, the PI-RADS scores from corresponding 
sectors from the base and the apex were aggregated to 4 quadrants 
(base left/right; apex left/right) by assigning the highest reader 
score for each quadrant. For side-based analysis the scores were 
further aggregated by assigning the highest score from quadrant-
based analysis to each corresponding side and for patient-based 
analysis, the reader scores were aggregated by assigning the high-
est reader score to each patient. The scores were dichotomized 
by considering 1–3 as negative, and 4–5 as positive. Second, the 
16 sectors from the standardized template sheets were summa-
rized into quadrants, consequently attributing the index lesion 
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  3 (9.1)
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  2 (6.1)
  9 (27.3)
11 (33.3)
  5 (15.2)
  0 (0)





PI-RADS scores Reader 2*
mpMRI
PPA mpMRIERC
      Thirty-three patients are in the dataset. *Data are absolute counts; data in parentheses are percentages.
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to the predominantly involved quadrant [i. e. epicenter quadrant 
(EC
Q
)] as shown before [18]. On digitalized histopathology the 
index lesion was directly attributed to the predominantly involved 
quadrant. Finally, careful side-by-side MRI-to-histopathology 
correlation was performed on a visual basis for every mismatch, 
rendering those lesions true positive on the readout, which were 
considered to be the same as the index lesion marked on histopa-
thology (i. e. lesions invading more than 1 quadrant, however the 
quadrant not being the EC
Q
) (fig. 1). A finding on MRI was rated 
true positive if it occurred in any of the regions comprising the 
index lesion as defined by the pathologist. A finding on MR was 
classified as false positive if its attributed region did not match 
the region of the index lesion as defined by the pathologist. If the 
region of the index lesion as defined by the pathologist was not 
rated as positive on MR, the MR finding was rated false negative.
Statistical Analysis
Continuous variables were summarized by using means and 
SD. Categorical variables were summarized as counts and propor-
tions. Kolmogorov-Smirnov test was used to assess the distribu-
tion of data.
Sensitivity and positive predictive value (PPV) for detection of 
index lesions were assessed using 2 × 2 contingency tables for the 
dichotomized data sets. Analysis was performed on a quadrant, 





set. Sensitivity and PPV for quadrant and side-based analysis was 
cumulated to one value. Differences between groups were tested 
using the McNemar test. Intra- and inter-reader agreement for the 
dualized scores was assessed using Cohen’s Kappa (κ). κ-values 
were stratified qualitatively by score (slight agreement 0.01–0.20; 
fair agreement 0.21–0.40; moderate agreement 0.41–0.60; sub-
stantial agreement 0.61–0.80; very good agreement 0.81–0.99) 
[19].
A p-value of < 0.05 was considered statistically significant. 
Statistical analysis was performed with IBM SPSS statistical soft-
ware (SPSS version 21; Chicago, Ill). 
Results
Patient Demographics
Thirty-three patients were included. The most preva-
lent GS was 3 + 4 (n = 14 patients), followed by 4 + 3 (n = 
11 patients), 4 + 4 (n = 3 patients), 4 + 5 (n = 3 patients), 
3 + 3 (n = 1 patient) and 5 + 3 (n = 1 patient). T-stage 
was < T3 for n = 16 patients ≥ T3 for n = 17 patients. 
Fifteen patients were stratified as “intermediate risk” and 
18 patients as “high risk”, according to the D’Amico risk 
group classification [20]. Patient demographics and his-
topathology data and are shown in table 1.
The frequency of PI-RADS 4 and 5 scores attributed 
to the corresponding epicenter quadrants was 69.7% (n 
= 23) for R1 and 60.6% (n = 20) for R2 for images ac-
quired with the mpMRI
PPA
. For images acquired with the 
mpMRI
ERC
 the frequency was 87.9% (n = 29) for R1 and 
75.8% (n = 25) for R2. The scores attributed to the corre-
sponding epicenter quadrants are shown in table 3.
Diagnostic Accuracy
On a quadrant basis cumulative sensitivity for the de-
tection of the index lesion was lower for both readers for 
images acquired with the mpMRI
PPA
 (R1, 0.67 and R2, 
0.61), compared with mpMRI
ERC
 (R1, 0.88 and R2, 0.76). 
Cumulative PPV was lower for images acquired with the 
mpMRI
PPA
 (R1, 0.81 and R2, 0.80), compared with mp-
MRI
ERC
 (R1, 0.91 and R2, 0.89). The difference between 
the two coil setups was not statistically significant (R1, p 
= 0.267 and R2, p = 0.508) (fig. 2, 3). Comparable results 
were achieved on a side-based analysis, namely cumula-
tive sensitivity being lower for both readers for images 
acquired with the mpMRI
PPA
 (R1, 0.70 and R2, 0.67), 
compared with mpMRI
ERC
 (R1, 0.91 and R2, 0.79). The 
same is true for the cumulative PPV for images acquired 
Fig. 2. A 54-year-old patient (PSA, 7.7 ng/ml) undergoing mpMRI 
of the prostate for detection and local staging. On the mpMRI
ERC
 
image set, the tumor (arrow) is clearly appreciated on the posterior 
median aspect of the apex, showing focal T2w hypointensity (A) 
and corresponding diffusion restriction on the ADC-map (B). On 
the mpMRI
PPA
 image set however, the tumor is less evident on 
T2w series (C) and does show no clearly appreciable diffusion 
restriction on the ADC map (D). Both readers only identified the 
tumor using the mpMRI
ERC
 image set (A, B).
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 (R1, 0.85 and R2, 0.88), compared 
with mpMRI
ERC
 (R1, 0.94 and R2, 0.93). The difference 
between the two coil setups, again was not statistically 
significant (R1, p = 0.267 and R2, p = 0.453). The same 
trend can be observed on a patient-basis, namely sensi-
tivity being lower for both readers for images acquired 
with the mpMRI
PPA
 (R1, 0.82 and R2, 0.76), compared 
with mpMRI
ERC
 (R1, 0.97 and R2, 0.85), the difference 
not being statistically significant (R1, p = 0.063 and R2, 
p = 0.375). Results of the assessment of diagnostic accu-
racy are shown in table 4.
Inter- and Intra-reader Agreement
Interreader agreement across all sub-analyses was 
good (κ range 0.64–0.76) for mpMRI
PPA
 and fair-very 
good (κ range 0.3–0.83) for mpMRI
ERC
, respectively. 
Intrareader agreement across all sub-analyses was fair-
good (κ range 0.25–0.72) for Reader 1 and moderate-very 
good (κ range 0.53–0.84) for Reader 2, respectively. 
Fig. 3. A 56-year-old patient undergoing mpMRI of the prostate for local staging of a bioptically diagnosed 4 
+ 3 tumor on the right side of the gland. On the mpMRI
ERC
 image set, the tumor (arrow) is clearly appreciated 
on the postero-lateral aspect of the right midgland, showing focal T2w hypointensity (A) and corresponding 
diffusion restriction on the ADC-map (B). The same is true for the mpMRI
PPA
 image set (C, D). Both readers 
correctly identified the tumor using both image sets. Reconstructed whole-mount histopathology (E) reveals a 4 
+ 3 tumor (approximately 25 mm2) on the postero-lateral aspect of the peripheral zone, at the level of the right 
midgland (E, green ROI). Both readers correctly identified the tumor by attributing a PI-RADS score of 4 to the 
corresponding quadrant, using the mpMRI
ERC




Receiver coil equipment is an important determinant 
of image quality in MRI of the prostate. Due to the pos-
sibility to be placed directly in close proximity of the 
posterior circumference of the organ, a high SNR can be 
achieved by means of an ERC, however potentially at the 
expense of increased artifacts [21] and higher costs. Our 
results, demonstrating that prostate cancer foci may be 
detected without significantly lower sensitivity by use of 
a PPA receiver coil as compared to an ERC, suggest that 
the potentially lower SNR does not translate into a lower 
diagnostic performance.
Whether to use an ERC or not is a matter of intense 
debate in prostate imaging. Apart from investigating 
image quality, some authors already conducted studies 
comparing the diagnostic accuracy of various coil setups. 
For local cancer staging, the use of an ERC as compared 
to PPA receiver coil equipment alone seems favorable, 
Gleason 4 + 3
25 mm2
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particularly at lower field strengths [22, 23]. Therefore, 
the European Society of Urogenital Radiology still rec-
ommends to use the ERC for local staging of prostate 
cancer on a 1.5T MRI in their recently updated guide-
lines [15]. For detection of cancer foci, there is no clear 
recommendation on the choice of receiver coil setup, es-
pecially when performing MRI at higher field strengths 
(3T). While Turkbey et al. [14] demonstrated better sen-
sitivity and PPV on images acquired with the ERC as 
compared to PPA (ERC 0.76 and 0.80; PPA 0.45 and 
0.64) for all tumors, a sub-analysis of dominant tumors 
did not show such a distinct difference (sensitivity of 
ERC 0.85; sensitivity for PPA 0.75). These findings are 
in accordance with our results with an overall sensitivity 
for detection of index lesions of 0.82 (mean value of R1, 
R2) for the mpMRI
ERC
 image set and 0.64 (mean value 
of R1, R2) for the mpMRI
PPA
 image set, respectively. 
The ERC image set showed a tendency towards higher 
sensitivity as compared to the image set acquired with 
the PPA receiver coil only, however, differences were not 
statistically significant. Another recent study supports 
our findings by demonstrating insignificant differences 
between receiver coil setups for the detection of index 
lesions [11]. Our achieved sensitivities of 0.76–0.97 on a 
per patient basis, are lower than the achieved sensitivities 
in the aforementioned study (0.96–0.97). A possible ex-
planation may be the different reference standards used 
in the 2 studies (MRI-TRUS fusion biopsy vs. prostatec-
tomy specimens). 
Another study [24] investigating the diagnostic per-
formance of images acquired without an ERC found that 
index lesions can be detected with an average sensitivity 
and PPV of 60.2 and 65.3%, respectively. When correct-
ing for a mismatch in terms of localization, similarly to 
the matching procedure used in our study, the overall 
performance rose to 75.9 and 82.6%, which is compara-
ble with our results (sensitivity average R1, R2 for both 
coil combinations, 0.73 and PPV, 0.85). The difference 
in sensitivity between the two receiver coil combinations 
in our study on a patient basis translated to n = 5 and 3 
patients for R1 and R2, respectively which were missed. 
The reason for the false negatives may be rooted in the 
reduced SNR provided by the PPA coil setup. This de-
crease in SNR may be minimized by increasing the num-
ber of averages for PPA acquisition, a solution that will 
be entailed by an increase in acquisition time, however. 
To reliably detect prostate cancer is one of the major 
tasks of mpMRI. Its ability in doing so varies significantly 
in the literature [25–28] and rises up to > 90% when as-
sessed on a patient basis (sensitivity range 79–96%) [29–
33]. These results are comparable with our study, where 
sensitivity ranged between 0.85 and 0.97 with and 0.76 
and 0.82 without the usage of an ERC, and demonstrate 
that images acquired without an ERC may be sufficient 
for the purpose of detection of prostate cancer. Inter- and 
intra-reader agreement in our study was within the range 
of previously published results [34–37] and did not differ 
between the two coil setups investigated. 
Several limiting factors are associated with the use of 
an ERC, more precisely patient acceptance, increased 
costs and associated artifacts. Therefore, further efforts 
must be undertaken in order to optimize MRI sequences 
up to a level where image quality does not compromise 
diagnostic performance. We think that with additional 
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